costos económicos en el tratamiento farmacológico del paciente con diabetes mellitus tipo 2. estudio de pacientes en consulta externa de medicina interna de un hospital de segundo nivel de la ciudad de méxico
Clicks: 162
ID: 233398
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
162 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #137 of 219 articles by views in journal of anatomy
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 219 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
La diabetes mellitus tipo 2 (DM2) es considerada un problema de salud pública global. Es la primera causa de morbilidad-mortalidad en el país. Representa una enfermedad de alto costo para los sistemas de salud, con un gasto de 370 billones de dólares al año, que se estima alcanzará los 490 billones de dólares para 2030...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (56 words).
Try re-searching for a better abstract.
| Reference Key |
ramrez-hinojosa2017saludcostos
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Juan Pablo Ramírez-Hinojosa;Rogelio Zacarías-Castillo;Margarita Torres-Tamayo;Erika Karina Tenorio-Aguirre;Alfredo Torres-Viloria |
| Journal | journal of anatomy |
| Year | 2017 |
| DOI |
10.21149/7944
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.